Inogen to Announce Second Quarter 2022 Financial Results on August 4, 2022
July 07 2022 - 4:01PM
Business Wire
Inogen, Inc. (Nasdaq: INGN), a medical technology company
offering innovative respiratory products for use in the homecare
setting, announced that it will release second quarter 2022
financial results after market close on Thursday, August 4, 2022.
The Company will host a corresponding conference call beginning at
2:00 pm PT/5:00 pm ET.
Individuals interested in listening to the conference call may
do so by dialing:
US domestic callers (877) 841-3961
International callers (201) 689-8589
Please reference Inogen to join the call. To listen to a live
webcast, please visit the Investor Relations section of Inogen's
website at: http://investor.inogen.com/.
A replay of the call will be available beginning, August 4,
2022, at 4:00pm PT/7:00pm ET through 4:00pm PT/7:00pm ET on August
18, 2022. To access the replay, dial (877) 660-6853 or (201)
612-7415 and reference Conference ID: 13730720. The webcast will
also be available on Inogen's website for one year following the
completion of the call.
Inogen has used, and intends to continue to use, its Investor
Relations website, http://investor.inogen.com/, as a means of
disclosing material non-public information and for complying with
its disclosure obligations under Regulation FD. For more
information, visit http://investor.inogen.com/.
About Inogen
We are a medical technology company offering innovative
respiratory products for use in the homecare setting. We primarily
develop, manufacture and market innovative portable oxygen
concentrators used to deliver supplemental long-term oxygen therapy
to patients suffering from chronic respiratory conditions.
For more information, please visit www.inogen.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220707005154/en/
Agnes Lee 650.677.9138 alee@inogen.net
Inogen (NASDAQ:INGN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Inogen (NASDAQ:INGN)
Historical Stock Chart
From Sep 2023 to Sep 2024